A feasibility study of adjuvant therapy with UFT/LV plus oxaliplatin following curative resection for stage III colorectal cancer
Not Applicable
Recruiting
- Conditions
- colorectal cancer
- Registration Number
- JPRN-UMIN000003381
- Lead Sponsor
- Toho University School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 45
Inclusion Criteria
Not provided
Exclusion Criteria
1)Multiple malignancies within five years 2) Other severe complications, such as pulmonary emphysema, pulmonary fibrosis, hyper pulmonary emphysema,paralysis intestinal, intestinal obstruction, uncontrolable diabetes, cirrhosis, uncontrollable hypertension, myocardial infarction within six months, angina. 3)Diarrhea 4) Pregnant 5)Evidence of psychiatric disability interfering with enrollment to clinical trial 6)Patients judged inappropriate for this study by physicians
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Patients ratio with completion of adjuvant TEGAFOX therapy
- Secondary Outcome Measures
Name Time Method